Strana 1 od 16 výsledky
BACKGROUND OF THE INVENTION
Field of the Invention
The present invention relates to pharmaceutical compositions, particularly to aminoalkyl esters of mycophenolic acid and derivatives thereof, and to their use as immunosuppressive and anti-inflammatory agents. For example, they are useful for
BACKGROUND OF THE INVENTION
This invention relates to a series of guanidine derivatives characterized by an (aryloxy or arylamino) alkyl substituent. In particular, this invention relates to guanidine derivatives useful as anti-inflammatory agents.
Substituted guanidines are known in the art. U.S.
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to compositions employing 3'-azido-3'-deoxythymidine (hereinafter azidothymidine or AZT) and their use in the treatment of psoriasis.
2. Description of the Related Art
Psoriasis is a common skin disorder
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to pharmaceutical compositions, particularly to the morpholinoethyl ester of mycophenolic acid and certain simple ester derivatives of the phenolic hydroxyl group, and to their use as immunosuppressive and
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to pharmaceutical compositions, particularly to the morpholinoethyl ester of mycophenolic acid and certain simple ester derivatives of the phenolic hydroxyl group, and to their use as immunosuppressive and
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to pharmaceutical compositions, particularly to the morpholinoethyl ester of mycophenolic acid and certain simple ester derivatives of the phenolic hydroxyl group, and to their use as immunosuppressive and
Priority is claimed to provisional patent application Ser. No. 60/011,078, filed Feb. 2, 1996.
FIELD OF THE INVENTION
The present invention relates to certain phosphoethanolamine conjugates of vitamin D compounds, pharmaceutically acceptable salts thereof, and to pharmaceutical compositions thereof.
The present invention relates to certain novel phosphocholine derivatives of retinoids, also known as Vitamin A-type compounds, useful as anti-inflammatory, antitumor and anti-psoriatic agents, in addition to the art-recognized therapeutic activities attributed to such retinoids, and pharmaceutical
FIELD OF THE INVENTION
1. Field of the Invention
The present invention relates to pharmaceutical compositions, particularly to aminoalkyl esters of mycophenolic acid and derivatives thereof, and to their use as immunosuppressive and anti-inflammatory agents. For example, they are useful for treating
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to pharmaceutical compositions, particularly to aminoalkyl esters of mycophenolic acid and derivatives thereof, and to their use as immunosuppressive and anti-inflammatory agents. For example, they are useful for
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to pharmaceutical compositions, particularly to aminoalkyl esters of mycophenolic acid and derivatives thereof, and to their use as immunosuppressive and anti-inflammatory agents. For example, they are useful for
Priority is claimed to provisional patent application Ser. No. 60/008,314, filed Dec. 7, 1995.
FIELD OF THE INVENTION
The present invention relates to novel, therapeutically active fatty alkyl and alkenyl ether glycerophospholipids bearing a defined heterocyclic (Het) substituent on the ethanolamine
This application claims priority to provisional application Ser. No. 60/008,350, filed Dec. 7, 1995.
FIELD OF THE INVENTION
The present invention relates to novel, therapeutically active fatty alkyl and alkenyl ether glycerophospholipids bearing a 3-(2-imidazolinyl)-2-imidazolinyl or 2-imidazolinyl
BACKGROUND OF THE INVENTION
This invention is directed to compounds which act as antagonists of the leukotrienes and inhibitors of their biosynthesis.
The leukotrienes are a novel group of biologically active mediators derived from arachidonic acid through the action of lipoxygenase enzyme systems.
DESCRIPTION OF THE INVENTION
The present invention relates to p-aminophenols and derivatives thereof which prevent leukotriene formation in macrophages and as such are useful, for example, as antiallergy agents, anti-inflammatory agents and in the treatment of psoriasis. These compounds have the